Skip to main content
. 2016 Jan 27;7(8):9163–9174. doi: 10.18632/oncotarget.7036

Figure 2. Distinct regulation of S6K1 signaling in DLBCL subtypes.

Figure 2

A. DLBCL lines were treated with GSK690693 (5μM) and MK2206 (5μM) for 1h or 24h before Western blotting. B. Cell lines were treated with PF-4708671 (10μM) or GSK690693 (5μM) and cell viability was measured after 72h by trypan blue staining followed by Cellometer reading (n = 3). Asterisk indicates p < 0.05 C. Cell lines were treated with the indicated compounds for 24h. ABC cells are colored in red. GCB are colored in blue. Intermediate cells are colored in gray.